Skip to content

Mindful Eating in the treatment of Obesity

Mindful Eating in the treatment of Obesity - ATENTO study - ATENTO Mindful Eating in the treatment of Obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-22p3nn2
Enrollment
Unknown
Registered
2021-05-31
Start date
2018-01-11
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Control group: volunteers received traditional nutritional guidance, with a low calorie diet plan and guidance on eating behavior (number of participants = 50). Intervention group 1: volunteers partic
F02.463.551
G07.203.650.240

Sponsors

Hospital das Clínicas da Faculdade de Medicina da USP
Lead Sponsor
Hospital das Clínicas da Faculdade de Medicina da USP
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Women between the ages of 18 and 50 with a BMI between 30 and 39.9kg/m2.

Exclusion criteria

Exclusion criteria: Male gender; age over 50 or under 18; pregnancy; lactation; menopause; iliterate individuals; individuals not adhering to the project proposal; undergoing bariatric surgery or already on a weight loss program; endocrine diseases; genetic diseases; heart disease; nephropathy; liver disease; use of medications that cause weight gain; cognitive deficit; active psychiatric illness

Design outcomes

Primary

MeasureTime frame
After the intervention, it was observed that all groups showed weight reduction, variation that was similar in the three groups. P equal to 0.692. Control group: -3.9 percent more or less 5.7 Intervention Group 1: -3.3 percent more or less 5.8 Intervention Group 2: -2.6 percent more or less 3.8;After the intervention, it was observed that all groups showed a reduction in body mass index, BMI Control group: P equal to 0.003 Intervention Group 1: P equal to 0.007 Intervention Group 2: P equal to 0.007

Secondary

MeasureTime frame
At the end of the study, it was observed through analysis of the 3 day food registry, performed using Avanutri software 4.0 version, that the consumption of energy and nutrients was similar between the groups. It was observed that in the control group there was a significant reduction in energy consumption, P equal to 0.002, quantity of carbohydrates in grams, P equal to 0.010, quantity of proteins in grams, P equal to 0.019, quantity of total fat in grams, P equal to 0.001 and in percentage, P less than 0.001, amount of saturated fat in grams, P equal to 0.001 and in percentage, P equal to 0.041, amount of monounsaturated fat in grams, P equal to 0.003, cholesterol,P equal to 0.015 and dietary fiber, P equal to 0.001. In intervention group 1, there was a reduction in energy consumption, P equal to 0.004, amount of carbohydrates in grams, P equal to 0.005 and fiber P equal to 0.022. In intervention group 2, there was a reduction in energy consumption, P equal to 0.022, amount of carbohydrates in grams, P equal to 0.046, amount of total fat in grams, P equal to 0.016, amount of saturated fat in grams, P less than 0.001 and in percentage, P equal to 0.002, amount of monounsaturated fats in grams, P equal to 0.006 and fiber, P equal to 0.002.;Clinical and laboratory analysis indicated that the mean blood pressure, heart rate, blood glucose, insulin, HOMA-IR, total cholesterol and liver fractions and enzymes were within the normal range at the beginning and at the end of treatment, and were similar in the three groups, except for the total cholesterol, which at the end of the study was higher in the intervention group 1 than in the intervention group 2, P equal to 0.042. At the end of the study, it was also observed that patients in the control group showed improvement in several metabolic parameters such as systolic blood pressure, P equal to 0.019, non-HDL-c, P equal to 0.017, HDL-c, P equal to 0.015 and TG, P less than 0.001. The patients in intervention group 1 ha

Countries

Brazil

Contacts

Public ContactMaria Edna de Melo
medna@usp.br+55 11 2661-7516

Outcome results

None listed

Source: REBEC (via WHO ICTRP)